Lipolytic Injection in Apgujeong | Eugene’s Skin Clinic
What are Lipolytic Injections?
EU:GENES Clinic’s Lipolytic Injections are a non-invasive aesthetic treatment that precisely removes fat from specific areas without surgery. By injecting clinically approved fat-dissolving solutions, fat cells are broken down and naturally eliminated through the body’s metabolic process, creating a smooth and refined body contour.
1-1. Ideal Candidates
● Those struggling with stubborn localized fat that doesn't respond to diet or exercise.
● Those wanting immediate improvement in areas like the double chin, arms, or abdomen.
● Those who prefer a simple procedure without the burden of surgery or anesthesia.
● Those who want a quick treatment with minimal downtime for a fast return to daily life.
2. EU:GENES Clinic's 3 Core Solutions
● 2-1. Newfit: Optimizes the internal metabolic environment to maximize the effectiveness of lipolytic injections.
● 2-2. Wegovy (Semaglutide): Induces overall body fat reduction to provide a synergistic effect when combined with injections.
● 2-3. Mounjaro (Tirzepatide): Precisely manages stubborn fat layers through powerful metabolic regulation.
3. Targeted Areas & Synergy Programs
● 3-1. Target Areas: Double chin, abdomen, love handles, thighs, arms, and lower back.
● 3-2. Body Tightening Synergy: Combines Body Microwave or HIFU to prevent skin sagging after fat reduction.
● 3-3. Precision Contouring: Completes a smooth silhouette with injection techniques tailored to individual fat thickness.
4. Why Choose EU:GENES Skin Clinic in Apgujeong?
● Physician-Guided Technique: Experienced doctors perform procedures safely and delicately based on anatomical expertise.
● Customized Treatment Planning: Determines the optimal dosage by measuring fat thickness through 1:1 consultation.
● Global Patient Support: Provides seamless English consultation and private care for international patients.
● Safety & Integrity: Guarantees reliable results by using only genuine, safety-proven solutions in precise amounts.
